Bob D. Rush
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 3
- Pharmacogenetics and Drug Metabolism 2
-
- Gastrointestinal motility and disorders 3
- Co-authors
- Mary J. Ruwart (17 shared papers)Karen F. Wilkinson (11 shared papers)Thomas J. Vidmar (4 shared papers)Philip S. Burton (3 shared papers)Keith S. Henley (2 shared papers)Henry D. Appelman (2 shared papers)Gordon L. Bundy (1 shared paper)Jed F. Fisher (1 shared paper)
- Journals
- Pharmaceutical Research (6 papers)Journal of Medicinal Chemistry (4 papers)Hepatology (3 papers)Prostaglandins (2 papers)Biochemical Pharmacology (1 paper)
- Partner nations
- United States
In The Last Decade
Bob D. Rush
23 papers receiving 750 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 148
- Hepatology 113
- Pharmaceutical Science 86
- Gastroenterology 31
- Organic Chemistry 140
Countries citing papers authored by Bob D. Rush
This map shows the geographic impact of Bob D. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob D. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob D. Rush more than expected).
Fields of papers citing papers by Bob D. Rush
This network shows the impact of papers produced by Bob D. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob D. Rush. The network helps show where Bob D. Rush may publish in the future.
Co-authors
The 25 scholars most cited alongside Bob D. Rush, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 97 | |
| 2 | 1989 | 87 | |
| 3 | 1996 | 85 | |
| 4 | 1997 | 74 | |
| 5 | 1976 | 69 | |
| 6 | 2002 | 68 | |
| 7 | 1992 | 60 | |
| 8 | 1988 | 52 | |
| 9 | 1993 | 47 | |
| 10 | 1991 | 41 | |
| 11 | 1986 | 34 | |
| 12 | 1993 | 30 | |
| 13 | 1992 | 26 | |
| 14 | 1984 | 17 | |
| 15 | 1980 | 14 | |
| 16 | 1984 | 14 | |
| 17 | 1984 | 14 | |
| 18 | 2007 | 10 | |
| 19 | 1990 | 7 | |
| 20 | 1993 | 5 |
About Bob D. Rush
Bob D. Rush is a scholar working on Pharmacology, Gastroenterology, Pharmaceutical Science, Infectious Diseases and Hepatology, having authored 23 papers that have together received 855 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), Gastrointestinal motility and disorders (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Drug Solubulity and Delivery Systems (2 papers), Herpesvirus Infections and Treatments (2 papers), Liver physiology and pathology (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Pharmacology (148 citations), Hepatology (113 citations), Pharmaceutical Science (86 citations), Gastroenterology (31 citations) and Organic Chemistry (140 citations). Bob D. Rush has collaborated with scholars based in United States. Frequent co-authors include Mary J. Ruwart, Karen F. Wilkinson, Thomas J. Vidmar, Philip S. Burton, Keith S. Henley, Henry D. Appelman, Gordon L. Bundy, Jed F. Fisher, Alan S. Nies and Grant R. Wilkinson. Their work appears in journals such as Pharmaceutical Research, Journal of Medicinal Chemistry, Hepatology, Prostaglandins and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.